Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 7/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 9/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 9/20 | 0.37 |
| ▸ | HPGDS | O60760 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16757859 | 0.92 | CYP4F2 (0.36) | GPR119CYP4F2CYP4A11HPGDS | |
| SCHEMBL16768907 | 0.86 | GPR119 (0.42) | GPR119CYP4F2CYP4A11HPGDS | |
| SCHEMBL16757782 | 0.84 | GPR119 (0.43) | GPR119CYP4F2CYP4A11HPGDS | |
| SCHEMBL16758058 | 0.84 | CYP4F2 (0.36) | GPR119CYP4F2CYP4A11HPGDS | |
| SCHEMBL16758262 | 0.84 | GPR119 (0.42) | GPR119CYP4F2CYP4A11 | |
| SCHEMBL16758259 | 0.84 | GPR119 (0.42) | GPR119CYP4F2CYP4A11 | |
| SCHEMBL16758175 | 0.83 | CYP4F2 (0.36) | GPR119CYP4F2CYP4A11HPGDS | |
| SCHEMBL16757793 | 0.82 | GPR119 (0.43) | GPR119CYP4F2CYP4A11HPGDS | |
| SCHEMBL16757861 | 0.81 | CNR2 (0.38) | GPR119CYP4F2CYP4A11 | |
| SCHEMBL18849013 | 0.81 | CNR2 (0.38) | GPR119CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3074384-A1 | AMIDE DERIVATIVES FOR GPR119 AGONIST | Chong Kun Dang Pharmaceutical Corp. (KR) | 2016-10-05 | — | — | EP | disclosed |
| WO-2015080446-A1 | AMIDE DERIVATIVES FOR GPR119 AGONIST | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2015-06-04 | — | — | WO | disclosed |